Valencell, a Raleigh, North Carolina-based developer of performance biometric data sensor technology, secured more than $7m in Series C financing.
Backers included WSJ Joshua Fund, TDF Ventures, True Ventures and Best Buy Capital.
The company, which has raised more than $13m in venture funding and more than $3 million in grants, intends to use the funds for the further technological development, sales and marketing of its sensors.
Founded in 2006 and led by newly appointed CEO Michael Dering, Valencell provides PerformTek®-powered biometric sensors, which measure real-time heart rate and activity continuously on anyone, doing anything. PerformTek sensors are available in multiple form factors, making them available for all parts of the body, including the ears. Ideal for consumer electronics manufacturers, mobile device and accessory makers, sports and fitness brands, gaming companies, headset and ear bud manufacturers, the sensors are currently powering four wearable products.